| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 264.20B | 252.26B | 257.20B | 243.17B | 227.37B | 225.32B |
| Gross Profit | 41.43B | 42.59B | 39.55B | 32.29B | 30.39B | 29.38B |
| EBITDA | 22.73B | 24.81B | 22.10B | 16.62B | 15.55B | 15.10B |
| Net Income | 12.25B | 10.32B | 11.98B | 7.51B | 6.56B | 6.70B |
Balance Sheet | ||||||
| Total Assets | 214.85B | 228.95B | 233.55B | 231.48B | 221.40B | 216.02B |
| Cash, Cash Equivalents and Short-Term Investments | 52.10B | 47.28B | 50.41B | 45.74B | 46.98B | 51.64B |
| Total Debt | 8.13B | 8.28B | 8.32B | 7.01B | 8.35B | 11.16B |
| Total Liabilities | 69.74B | 73.59B | 85.84B | 89.07B | 86.91B | 86.47B |
| Stockholders Equity | 145.04B | 155.29B | 147.65B | 142.35B | 134.43B | 129.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.72B | 11.08B | 1.71B | 5.83B | 3.88B |
| Operating Cash Flow | 0.00 | 6.64B | 15.08B | 7.80B | 9.69B | 7.93B |
| Investing Cash Flow | 0.00 | -5.91B | -5.80B | 4.32B | -5.30B | -9.81B |
| Financing Cash Flow | 0.00 | -5.47B | -6.84B | -3.37B | -5.45B | -1.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥262.06B | 13.33 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥685.36B | 16.51 | ― | 2.15% | 0.46% | 38.67% | |
77 Outperform | ¥47.08B | 10.24 | 7.09% | 3.06% | 9.75% | 22.98% | |
77 Outperform | ¥97.86B | 11.64 | ― | 4.38% | -6.07% | 44.83% | |
64 Neutral | ¥170.58B | 17.02 | ― | 2.87% | -1.92% | -12.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |